Delivery Order SPE2DB22D1202-SPE2DB25FUZB9

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Simvastatin 40 mg tablets in quantities of 1,000 tablets. The contract is a firm-fixed-price, delivery order contract with a ceiling value of $3,332.84 and a performance period through August 8, 2023. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Simvastatin 10 mg tablets. The contract has a ceiling value of $2,179.14 and runs through December 10, 2024. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,082.30, is for the delivery of 1,000 units of Simvastatin 40 mg tablets. The delivery order is placed under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 4,566,816,327 units of Simvastatin 40 mg tablets. The fixed-price delivery order is valued at $4,772.19 and has an ultimate completion date of January 2, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,763.52, is a Delivery Order for the supply of 4,565,047,099 tablets of Simvastatin 40 mg. The award has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award for $1,079.94 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the supply of 1,000 units of 20 mg Simvastatin tablets. The contract has an ultimate completion date of February 2, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2014|SPE2DB24FC49Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,856.62 Firm Fixed Price contract is for the delivery of 4565172106 - SIMVASTATIN 40 MG TABLET 1000S, with a completion date of July 18, 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $5,534.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of 4,564,614,819 tablets of Simvastatin 10 mg, a generic cardiovascular medication. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This is a delivery order (SPE2DB24FN7V7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,571,363 units of Atorvastatin 40 mg tablets. The contract has a ceiling value of $1,140.61 and a completion date of May 13, 2024. It is a Firm Fixed Price contract with no set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with the ID SPE2DB20D3505|SPE2DB24FU2J5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order, has a Firm Fixed Price pricing type and a ceiling value of $2,598.26. It is for the supply of EZETIMIBE-SIMVASTATIN 10-20 MG 30S, a pharmaceutical product, with a performance location in Conshohocken, Pennsylvania. The contract has an ultimate completion date of May 8, 2024....
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUZB9
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Simvastatin 40 mg tablets. The contract has a firm fixed price of $1,504.93 and a period of performance through May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is a part of that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/31/25, 9:43 AM